Bioxytran, Inc (BIXT) stock
BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
Bioxytran profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Bioxytran's profit margin for the twelve months ending Jun 30, 2018 was -21.6%. For fiscal 2017 it was -166.6%, against -282.7% the year before. The highest annual figure on record is -166.6% in fiscal 2017.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | -166.6% | +116.0 |
| FY2016 | Dec 31, 2016 | -282.7% | +538.3 |
| FY2015 | Dec 31, 2015 | -820.9% | −332.2 |
| FY2014 | Dec 31, 2014 | -488.7% | −62.5 |
| FY2013 | Dec 31, 2013 | -426.2% | +306.7 |
| FY2012 | Dec 31, 2012 | -732.9% | +5076.4 |
| FY2011 | Dec 31, 2011 | -5809.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2018 | Jun 30, 2018 | -1.4% | +658.4 |
| Q1 FY2018 | Mar 31, 2018 | -5.0% | +863.5 |
| Q4 FY2017 | Dec 31, 2017 | -268.4% | −500.9 |
| Q3 FY2017 | Sep 30, 2017 | 43.7% | +255.2 |
| Q2 FY2017 | Jun 30, 2017 | -659.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -868.6% | – |
| Q4 FY2016 | Dec 31, 2016 | 232.4% | – |
| Q3 FY2016 | Sep 30, 2016 | -211.6% | – |
See a number that looks wrong?